Target intelligence / Profile preview

Cadherin-1 (E-cadherin) (CDH1)

Target
CDH1
Molecular classification
Cell adhesion molecule (CAM), Type I classical cadherin
01

Overview

Cadherin-1, widely known as E-cadherin, is a 120 kDa transmembrane glycoprotein that serves as a master regulator of calcium-dependent cell-cell adhesion in epithelial tissues. The 'O-mannosylated 70 kDa E-cadherin' refers to a specific pathological fragment or state of the protein associated with its post-translational modification by the POMT1/POMT2 enzyme complex. O-mannosylation is essential for the stability and functional localization of E-cadherin at the cell membrane; in the absence of this modification, the protein becomes unstable and is proteolytically cleaved into a characteristic 70 kDa fragment. This fragment and the overall loss of E-cadherin O-mannosylation are key biomarkers for gastric cancer progression and the epithelial-mesenchymal transition (EMT). While E-cadherin is primarily a tumor suppressor, its specific glycoforms and degradation products are targets for experimental monoclonal antibodies and diagnostic assays aimed at monitoring tumor invasiveness and restoring adhesive function.

Other names
E-cadherinCD324Epithelial cadherinsE-cad70 kDa E-cadherin fragmentCalcium-dependent adhesion protein epithelial
02

Mechanism of action

Restoration of cell-cell adhesion, inhibition of epithelial-mesenchymal transition (EMT), stabilization of the mature 120 kDa protein, and neutralization of pro-oncogenic soluble fragments.

03

Biological functions

Cell-cell adhesionEpithelial integrity maintenanceSignal transduction (Wnt/beta-catenin pathway)Tissue morphogenesisRegulation of epithelial-mesenchymal transition (EMT)
04

Disease associations

CancerGastric cancerHereditary Diffuse Gastric Cancer (HDGC)Breast cancer (Lobular carcinoma)Metastasis
05

Safety considerations

Disruption of normal epithelial barriers (skin, gut, mucosa)Potential for promoting cell dissociation in healthy tissuesSkin and mucosal toxicity associated with systemic adhesion modulation
06

Interacting drugs

HECD-1 (Experimental monoclonal antibody)

3 more in the full profile.

07

Biomarkers

70 kDa E-cadherin fragment levelsSoluble E-cadherin (sE-cad) concentrationPOMT1 (Protein O-mannosyltransferase 1) expressionE-cadherin O-mannosylation status (detected via Concanavalin A lectin binding)

Beyond the preview

Go deeper on Cadherin-1 (E-cadherin) (CDH1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cadherin-1 (E-cadherin) (CDH1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call